Project Oncology® CME presents a wide array of oncology CME topics designed to educate and enlighten practitioners on late-breaking discoveries, novel treatment options, evolving methods of patient management, and more. The series provides cutting-edge updates on cancer biology, diagnosis, and multidisciplinary management, as well as evidence-based recommendations to achieve optimal patient outcomes. Each program is designed to be a short, easy-to-digest format of 15 to 30 minutes.
HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps
HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps
Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?
Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?
Diversity in HER2 Expression Among Gynecologic Cancers
Diversity in HER2 Expression Among Gynecologic Cancers
Significance of HER2 Expression in Solid Tumors
Significance of HER2 Expression in Solid Tumors
Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors
Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors
Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents
Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents
Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
Goals of Therapy for WHIM Syndrome (a Chronic Neutropenic Disorder)
WHIM Syndrome Management: The First FDA Approval for Patients
WHIM Syndrome Management: The First FDA Approval for Patients
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
